Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Waldenstrom's Disease”

94 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 94 results

Testing effectiveness (Phase 2)Ended earlyNCT01125293
What this trial is testing

Everolimus, Bortezomib and/or Rituximab in Patients With Relapsed/Refractory Waldenstrom's Macroglobulinemia

Who this might be right for
Waldenstrom's Macroglobulinemia
Dana-Farber Cancer Institute 46
Testing effectiveness (Phase 2)Study completedNCT00165295
What this trial is testing

Sildenafil Citrate in Waldenstrom's Macroglobulinemia

Who this might be right for
Waldenstrom's Macroglobulinemia
Dana-Farber Cancer Institute 30
Testing effectiveness (Phase 2)Study completedNCT02363439
What this trial is testing

Extension Study of IMO-8400 in Patients With Waldenström's Macroglobulinemia Who Completed Study 8400-401

Who this might be right for
Waldenstrom's Macroglobulinemia
Idera Pharmaceuticals, Inc. 5
Testing effectiveness (Phase 2)Ended earlyNCT00265928
What this trial is testing

Bortezomib and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
University of Virginia 46
Testing effectiveness (Phase 2)Study completedNCT02962401
What this trial is testing

Efficacity of Idelalisib and Obinutuzumab in Patient With Relapsed Refractory Waldenstrom's Macroglobulinemia

Who this might be right for
Waldenstrom Macroglobulinemia
French Innovative Leukemia Organisation 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT04624906
What this trial is testing

Bendamustine, Rituximab and Acalabrutinib in Waldenstrom's Macroglobulinemia

Who this might be right for
Waldenstrom Macroglobulinemia
Sunnybrook Health Sciences Centre 63
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07464210
What this trial is testing

Nemtabrutinib, Bortezomib, and Rituximab for WM

Who this might be right for
Waldenstrom Macroglobulinemia
Seoul National University Hospital 19
Testing effectiveness (Phase 2)Study completedNCT01470196
What this trial is testing

Carfilzomib, Rituximab and Dexamethasone in Waldenstrom's Macroglobulinemia

Who this might be right for
Waldenstrom's Macroglobulinemia
Dana-Farber Cancer Institute 31
Testing effectiveness (Phase 2)Study completedNCT00422799
What this trial is testing

Combination Bortezomib and Rituximab in Patients With Waldenstrom's Macroglobulinemia (WM)

Who this might be right for
Waldenstrom's Macroglobulinemia
Dana-Farber Cancer Institute 63
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07791498
What this trial is testing

Teclistamab In Waldenstrom's Macroglobulinemia

Who this might be right for
Waldenstrom's Macroglobulinemia
Massachusetts General Hospital 24
Early research (Phase 1)Study completedNCT00273936
What this trial is testing

Trial of AVN-944 in Patients With Advanced Hematologic Malignancies

Who this might be right for
Acute LeukemiaChronic LeukemiaMultiple Myeloma+3 more
Vertex Pharmaceuticals Incorporated 72
Not applicableStudy completedNCT04830046
What this trial is testing

Covid-19 Vaccine Responsiveness in MM and Waldenstrom

Who this might be right for
Multiple MyelomaWaldenstrom MacroglobulinemiaImmune System Disorder+1 more
Massachusetts General Hospital 146
Testing effectiveness (Phase 2)WithdrawnNCT00003512
What this trial is testing

Antineoplaston Therapy in Treating Patients With Recurrent or Refractory Waldenstrom's Macroglobulinemia

Who this might be right for
Waldenstrom Macroglobulinemia
Burzynski Research Institute
Not applicableStudy completedNCT00142155
What this trial is testing

Correlation of FC Gamma RIIIA Receptor Response in Patients With Waldenstrom's Macroglobulinemia

Who this might be right for
Waldenstrom's Macroglobulinemia
Dana-Farber Cancer Institute 300
Early research (Phase 1)Ended earlyNCT01078974
What this trial is testing

Pomalidomide, Dexamethasone and Rituximab in Waldenstrom's Macroglobulinemia

Who this might be right for
Waldenstrom's Macroglobulinemia
Steven P. Treon, MD, PhD 7
Early research (Phase 1)Study completedNCT00807677
What this trial is testing

Dose Escalation Study of TAK-901 in Subjects With Advanced Hematologic Malignancies

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic LeukemiaChronic Myelogenous Leukemia+9 more
Millennium Pharmaceuticals, Inc. 31
Early research (Phase 1)Looking for participantsNCT06980116
What this trial is testing

Dose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell Malignancies

Who this might be right for
Relapsed or Refractory B-cell MalignanciesChronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)Follicular Lymphoma (FL)+4 more
Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc. 85
Early research (Phase 1)Study completedNCT00150462
What this trial is testing

Safety Study of the Proteasome Inhibitor PR-171 (Carfilzomib for Injection) in Patients With Hematological Malignancies

Who this might be right for
Waldenstrom's MacroglobulinemiaNon-Hodgkin's LymphomaHodgkin's Disease+1 more
Amgen 48
Testing effectiveness (Phase 2)Study completedNCT00718419
What this trial is testing

Patients That Have Been Previously Been Treated in Waldenstrom's Macroglobulinemia or Multiple Myeloma

Who this might be right for
Waldenstrom's MacroglobulinemiaMultiple Myeloma
Eli Lilly and Company 56
Testing effectiveness (Phase 2)Study completedNCT00004107
What this trial is testing

Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Lymphoma or Waldenstrom's Macroglobulinemia

Who this might be right for
LeukemiaLymphoma
Garden State Cancer Center at the Center for Molecular Medicine and Immunology 18
Next Page